New Drug Approach Shrinks Lung Cancer Tumors and Halts Resistance
Researchers at the Stony Brook Cancer Center have developed a novel multi-targeted therapy, Gem-miR-129, designed to reduce non-small cell lung cancer tumors and overcome drug resistance. Published in the journal ... Read More